US Urges Justices Not To Review Drug Exec's $1M Tax Penalty
The U.S. Supreme Court should not accept a drug company executive's challenge to lower courts' findings that there is an objective standard for his reckless failure to report foreign bank accounts,...To view the full article, register now.
Already a subscriber? Click here to view full article